Globant S.A. (GLOB) Financial Statements
Globant S.A. (GLOB) reported trailing twelve-month revenue of $2.5B (up 1.6% year on year) and net income of $104.0M, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $282.0M.
Source: SEC EDGAR filings · read by EquiReason
GLOBGlobant S.A.Follow GLOB — free
—
Price chart with a free account
- Market cap
- 2.0B
- Annual P/E
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 12 Nov, in 19 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters.
| Line | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.41 | 0.52 | 0.66 | 0.81 | 1.30 | 1.78 | 2.10 | 2.42 | 2.45 | — | |
| Gross profit | 0.15 | 0.20 | 0.25 | 0.30 | 0.49 | 0.67 | 0.76 | 0.86 | 0.86 | — | |
| Operating income | 0.03 | 0.07 | 0.08 | 0.08 | 0.14 | 0.21 | 0.20 | 0.23 | 0.17 | — | |
| Pre-tax income | 0.04 | 0.07 | 0.07 | 0.08 | 0.12 | 0.19 | 0.20 | 0.21 | 0.14 | — | |
| Income tax | 0.01 | 0.02 | 0.02 | 0.02 | 0.03 | 0.04 | 0.04 | 0.04 | 0.04 | — | |
| Net income | 0.03 | 0.05 | 0.05 | 0.05 | 0.10 | 0.15 | 0.16 | 0.17 | 0.10 | — | |
| Diluted EPS ($) | 0.84 | 1.41 | 1.43 | 1.37 | 2.28 | 3.47 | 3.64 | 3.72 | 2.29 | — | |
| Diluted shares (bn) | 0.036 | 0.037 | 0.038 | 0.040 | 0.042 | 0.043 | 0.044 | 0.045 | 0.045 | — |
USD billions · SEC XBRL
Globant S.A. — questions
- What is Globant S.A.'s revenue?
- $2.5B over the twelve months to the latest filing, up 1.6% year on year, from its 10-Q and 10-K filings.
- What is Globant S.A.'s net income?
- $104.0M over the twelve months to .
- What is Globant S.A.'s free cash flow?
- $282.0M over the twelve months to .
Every figure on this page comes from Globant S.A.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.